Guidance on measuring family spillover effects in Health Technology Assessments (HTA) and Cost-Effectiveness Analyses (CEA) is provided in a paper by Campbell et al. (2024). The authors developed 15 recommendations through literature review, expert interviews, and a workshop to ensure consistent and transparent evaluation. The expert panel included patient advocates, health economists, outcomes researchers, a health policy expert, and a payer.
The recommendations are tailored for three stakeholder groups: HTA agencies, model developers, and data analysts specializing in family spillovers. These recommendations aim to standardize and enhance the assessment of family spillover effects in healthcare evaluations.
For additional details on these recommendations, refer to the full article here.
